CG Oncology Stock: Priced To Perfection On Future Pipeline Success (NASDAQ:CGON)
· seekingalpha.com
CG Oncology (CGON) rated Hold: $6.3B valuation prices in flagship NMIBC therapy and pipeline.
CG Oncology, Inc. ( CGON ) is a pre-revenue biopharmaceutical company that focuses on developing therapies for bladder cancer. The stock is currently trading at...